Edition:
United States

Karo Pharma AB (KARO.ST)

KARO.ST on Stockholm Stock Exchange

34.00SEK
15 Dec 2017
Change (% chg)

-1.00kr (-2.86%)
Prev Close
35.00kr
Open
35.00kr
Day's High
35.00kr
Day's Low
33.50kr
Volume
454,734
Avg. Vol
307,151
52-wk High
44.27kr
52-wk Low
22.66kr

Revenue & Earnings Per Share

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 17.58 198.20 35.91
P/E High - Last 5 Yrs. 17.52 280.37 45.35
P/E Low - Last 5 Yrs. 17.52 93.75 24.23
Beta 0.75 0.82 0.91
Price to Sales (TTM) 5.42 122.78 5.95
Price to Book (MRQ) 2.75 23.45 5.68
Price to Tangible Book (MRQ) -- 27.39 7.29
Price to Cash Flow (TTM) 15.01 108.78 24.49
% Owned Institutions -- 5.61 1.41

Dividends

  Company industry sector
Dividend Yield 0.78 0.28 1.49
Dividend Yield - 5 Year Avg 0.35 0.26 2.05
Dividend 5 Year Growth Rate -- 1.99 5.25
Payout Ratio(TTM) 0.00 96.58 46.14

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 60.98 -5.04 6.79
Sales (TTM) vs TTM 1 Yr. Ago 67.97 29.98 5.62
Sales - 5 Yr. Growth Rate -- 33.48 10.24
EPS (MRQ) vs Qtr. 1 Yr. Ago 129.92 -150.15 7.85
EPS (TTM) vs TTM 1 Yr. Ago 382.49 -- --
EPS - 5 Yr. Growth Rate -- 44.93 10.94
Capital Spending - 5 Yr. Growth Rate 15.70 41.51 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.55
Current Ratio (MRQ) 2.10 5.62 3.56
LT Debt to Equity (MRQ) 0.00 16.22 13.38
Total Debt to Equity (MRQ) 0.00 18.71 19.38
Interest Coverage (TTM) -3.83 -139.32 44.30

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 51.38 44.18 54.91
Gross Margin - 5 Yr. Avg. -- 55.78 52.46
EBITD Margin (TTM) 30.31 -- --
EBITD - 5 Yr. Avg -36.86 -215.66 15.63
Operating Margin (TTM) 21.59 -642.63 6.56
Operating Margin - 5 Yr. Avg. -43.06 -232.87 11.00
Pre-Tax Margin (TTM) 14.82 -611.04 7.41
Pre-Tax Margin - 5 Yr. Avg. -44.64 -233.04 11.41
Net Profit Margin (TTM) 27.39 -608.78 3.64
Net Profit Margin - 5 Yr. Avg. -30.81 -236.43 7.70
Effective Tax Rate (TTM) -84.78 15.53 24.28
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 7,468,754 22,314,532 851,801,741
Net Income/Employee (TTM) 2,045,783 -1,997,855 99,542,701
Receivable Turnover (TTM) -- 26.15 6.13
Inventory Turnover (TTM) -- 2.62 3.56
Asset Turnover (TTM) 0.41 0.42 0.96

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 11.17 -9.39 11.31
Return on Assets - 5 Yr. Avg. -9.05 0.28 12.28
Return on Investment (TTM) 12.41 -11.76 14.43
Return on Investment - 5 Yr. Avg. -13.05 3.42 16.07
Return on Equity (TTM) 16.59 -36.72 16.01
Return on Equity - 5 Yr. Avg. -18.16 5.75 17.27
  1 Year 3 Year 5 Year
Sales % 402.58 94.73 --
EPS (TTM) % 192.15 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Karo Pharma AB

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -3.12 -2.27 80 94
13 Week -13.39 -14.24 65 75
26 Week -16.99 -14.16 75 59
52 Week 29.60 22.16 99 58
YTD 36.98 27.93 99 51
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 3.75%
# of Holders: 10
Total Shares Held: 4,107,927
3 Mo. Net Change: 930,481
# New Positions: 1
# Closed Positions: 1
# Increased Positions: 6
# Reduced Positions: 3
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.